Format

Send to

Choose Destination
Nature. 2015 Apr 2;520(7545):57-62. doi: 10.1038/nature14344. Epub 2015 Mar 18.

Ferroptosis as a p53-mediated activity during tumour suppression.

Author information

1
Institute for Cancer Genetics, College of Physicians &Surgeons, Columbia University 1130 St Nicholas Ave, New York, New York 10032, USA.
2
1] Department of Pathology and Cell Biology, College of Physicians &Surgeons, Columbia University 630 West 168th Street, New York, New York 10032, USA [2] Herbert Irving Comprehensive Cancer Center, College of Physicians &Surgeons, Columbia University 1130 St Nicholas Ave, New York, New York 10032, USA.
3
1] Institute for Cancer Genetics, College of Physicians &Surgeons, Columbia University 1130 St Nicholas Ave, New York, New York 10032, USA [2] Department of Pathology and Cell Biology, College of Physicians &Surgeons, Columbia University 630 West 168th Street, New York, New York 10032, USA [3] Herbert Irving Comprehensive Cancer Center, College of Physicians &Surgeons, Columbia University 1130 St Nicholas Ave, New York, New York 10032, USA.

Abstract

Although p53-mediated cell-cycle arrest, senescence and apoptosis serve as critical barriers to cancer development, emerging evidence suggests that the metabolic activities of p53 are also important. Here we show that p53 inhibits cystine uptake and sensitizes cells to ferroptosis, a non-apoptotic form of cell death, by repressing expression of SLC7A11, a key component of the cystine/glutamate antiporter. Notably, p53(3KR), an acetylation-defective mutant that fails to induce cell-cycle arrest, senescence and apoptosis, fully retains the ability to regulate SLC7A11 expression and induce ferroptosis upon reactive oxygen species (ROS)-induced stress. Analysis of mutant mice shows that these non-canonical p53 activities contribute to embryonic development and the lethality associated with loss of Mdm2. Moreover, SLC7A11 is highly expressed in human tumours, and its overexpression inhibits ROS-induced ferroptosis and abrogates p53(3KR)-mediated tumour growth suppression in xenograft models. Our findings uncover a new mode of tumour suppression based on p53 regulation of cystine metabolism, ROS responses and ferroptosis.

Comment in

PMID:
25799988
PMCID:
PMC4455927
DOI:
10.1038/nature14344
[Indexed for MEDLINE]
Free PMC Article

Publication type, MeSH terms, Substances, Secondary source ID, Grant support

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center